IntriCon Corp. (NASDAQ:IIN) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday.
According to Zacks, “IntriCon designs, develops, engineers and manufactures microminiaturized medical and electronic products. The Company supplies microminiaturized components, systems and molded plastic parts, primarily to the hearing instrument manufacturing industry, as well as the computer, government, electronics, telecommunications and medical equipment industries. The Company has facilities in the United States, Asia and Europe. “
IntriCon Corp. (NASDAQ:IIN) opened at 6.14 on Wednesday. The stock’s market cap is $41.72 million. The stock’s 50 day moving average price is $4.91 and its 200 day moving average price is $5.34. IntriCon Corp. has a 52 week low of $4.12 and a 52 week high of $8.65.
IntriCon Corp. (NASDAQ:IIN) last released its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.23) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by $0.14. The company had revenue of $17 million for the quarter, compared to analyst estimates of $16.71 million. IntriCon Corp. had a positive return on equity of 2.36% and a negative net margin of 0.05%. On average, analysts forecast that IntriCon Corp. will post ($0.10) earnings per share for the current year.
Institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC raised its position in shares of IntriCon Corp. by 0.9% in the first quarter. Renaissance Technologies LLC now owns 171,500 shares of the company’s stock valued at $1,092,000 after buying an additional 1,500 shares during the period. Heartland Advisors Inc. acquired a new position in shares of IntriCon Corp. during the second quarter valued at approximately $2,136,000. AWM Investment Company Inc. acquired a new position in shares of IntriCon Corp. during the second quarter valued at approximately $294,000. Coe Capital Management LLC purchased a new stake in IntriCon Corp. during the second quarter valued at about $240,000. Finally, Bard Associates Inc. purchased a new stake in IntriCon Corp. during the second quarter valued at about $211,000. 23.33% of the stock is currently owned by institutional investors and hedge funds.
About IntriCon Corp.
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon Corp. and related companies with MarketBeat.com's FREE daily email newsletter.